Angiotensin-converting enzyme (ACE) inhibitors (ACEIs) and angiotensin II type‐1 receptor blockers (ARBs) are among the most widely prescribed drugs for the treatment of arterial hypertension, heart failure and chronic kidney disease. Here, ACE is linked to chronic kidney disease.